Xylometazoline linked with risk of serious arrhythmias?
- 29 Downloads
- National Pharmaceutical Regulatory Agency, Ministry of Health Malaysia. Xylometazoline: Increased Risk of Serious Ventricular Arrhythmia in Patients with Long QT Syndrome. Internet Document : 15 Mar 2019. Available from: URL: https://www.npra.gov.my/index.php/en/component/content/article/414-english/safety-alerts-main/safety-alerts-2019/
© Springer International Publishing AG 2019